期刊
TRENDS IN ENDOCRINOLOGY AND METABOLISM
卷 24, 期 11, 页码 537-545出版社
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tem.2013.05.009
关键词
maicrobiota; non-alcoholic steatohepatitis; inflammation; adipocytokines; insulin resistance
Non-alcoholic fatty liver disease (NAFLD) has emerged as a major health problem worldwide. Whereas overnutrition and obesity are crucially involved in the development of a simple fatty liver, it remains unclear why approximately 10% of all affected individuals develop the 'inflammatory' phenotype so-called non-alcoholic steatohepatitis (NASH). A link between the intestinal microbiota and the development of obesity and its metabolic consequences including NAFLD is becoming clearer. First clinical, but especially experimental, studies are suggesting that microbiotal factors are driving forces of hepatic steatosis and inflammation that involve Toll-like receptors and proinflammatory cytokines such as tumor necrosis factor-alpha (TNF alpha). Future studies focused on deciphering how manipulation of the gut microbiota might prove beneficial for patients with NAFLD are warranted.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据